In January 2026, Alaska and Hawaii became the latest states to introduce age restriction bills on weight-loss and muscle-building dietary supplements. The bills would restrict the sale of these products to those under 18 years of age.
Other states that have introduced and/or passed similar bills consist of Massachusetts, New York, New Jersey, Texas, New Hampshire, Virginia, Maryland, Washington, Illinois and Michigan, bringing the total states to 12.
On Jan. 20 Alaska State Representative Alyse Galvin (I) introduced Alaska House Bill 236 (HB 236).
“The authority to regulate the sale of weight-loss drugs and dietary supplements for weight loss or muscle building to minors is reserved to the state, and, except as specifically provided by statute, a municipality may not enact or enforce an ordinance regulating the sale of weight-loss drugs or dietary supplements for weight loss or muscle building to minors,” HB 236 reads.
On Jan. 21 Hawaii State Senators Joy San Buenaventura (D), Angus McKelvey (D), Carol Fukunaga (D), Tim Richards (D), Mike Gabbard (D) and Michelle Kidani (D) introduced Senate Bill 2284 (SB 2284). A second bill, Hawaii Senate Bill 2106 (SB 2106), was also introduced.
SB 2284 notably provides exceptions for vitamins, protein powders, protein drinks and foods marketed as containing vitamins or proteins “unless the product also contains an ingredient other than a vitamin or protein that would, considered alone, constitute a dietary supplement for weight loss or muscle building.” SB 2106 would “require retail establishments and delivery sellers to follow certain protocols regarding certain products to prevent access to minors to the restricted products.”
The Council for Responsible Nutrition (CRN) and Natural Products Association responded to the bills.
“CRN opposes the Alaska legislation that would restrict access to dietary supplements based on age because it is not supported by credible scientific evidence and risks unintended consequences for consumers and retailers,” said Jeff Ventura, vice president, communications at CRN. “There is no evidence demonstrating a causal link between dietary supplement use and the harms cited by proponents of the bill, and singling out FDA-regulated, lawful products does not address the complex underlying issues policymakers seek to solve. CRN urges lawmakers to focus on evidence-based approaches that protect public health without unnecessarily limiting consumer access to safe, federally regulated supplements.”
“SB 2106 is not based on a scientific assessment of risk. Peer-reviewed research does not support the notion that dietary supplements cause eating disorders, and restricting access to lawful, FDA-regulated products diverts attention from the real, complex drivers of these serious mental health conditions,” added Andrea Wong, PhD, senior vice president and chief science officer at CRN.”
Kyle Turk, vice president of government affairs at NPA said, “Alaska and Hawaii lawmakers are proposing policies that restrict responsible consumers’ access to safe products and penalize compliant businesses. These proposals, including Senate Bill 2106 in Hawaii, represent regulatory overreach and a deeply misguided approach to public health. Dietary supplements are already regulated under federal law and overseen by the U.S. Food and Drug Administration. When unsafe products appear, the agency has clear authority to remove them from U.S. commerce and enforce against bad actors. If enacted into law, these bills would result in fewer choices, higher costs and greater confusion in the marketplace, undermining sound science and personal freedoms.”
For more information, visit www.akleg.gov or www.capitol.hawaii.gov.
